Rights and permissions
About this article
Cite this article
Restrictive access to interferon-Β-1b criticised in France. Pharmacoecon. Outcomes News 260, 12 (2000). https://doi.org/10.1007/BF03275451
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03275451